Li Xiaoran, Wang Wenyun, Su Yu, Yue Zhongjin, Bao Junsheng
a Department of Urology , Gansu Nephro-Urological Clinical Center, Key Laboratory of Gansu Province for Urological Diseases, Lanzhou University Second Hospital , Gansu , China.
b Department of Pediatric Surgery , Lanzhou University Second Hospital , Gansu , China.
Ren Fail. 2017 Nov;39(1):120-129. doi: 10.1080/0886022X.2016.1254658.
To examine the effect of an aqueous extract of Radix Paeoniae Alba (RPA) on the formation of calcium oxalate (CaOx) stones and the potential mechanism underlying the effect.
An in vitro assay was used to determine whether the RPA extract prevents the formation of CaOx or promotes CaOx dissolution. We also investigated the efficacy of the extract in vivo as a preventive and therapeutic agent for experimentally induced CaOx nephrolithiasis in rats. Various biochemical, molecular, and histological parameters were assessed in kidney tissue and urine at the end of the in vivo experiment.
Significant dissolution of formed crystals (8.99 ± 1.43) and inhibition of crystal formation (2.55 ± 0.21) were observed in vitro after treatment with 64 mg/mL of the RPA extract compared with a control treatment (55.10 ± 4.98 and 54.57 ± 5.84, respectively) (p < .05). In preventive protocols, the RPA extract significantly reduced urinary and renal oxalate levels and increased urinary calcium and citrate levels compared to the control. In addition, the RPA preventive protocol significantly decreased osteopontin expression, renal crystallization, and pathological changes compared to the control. These changes were not observed in rats on the therapeutic protocol.
RPA is a useful agent that prevents the formation of CaOx kidney stones.
研究白芍水提取物(RPA)对草酸钙(CaOx)结石形成的影响及其潜在作用机制。
采用体外试验来确定RPA提取物是否能预防CaOx结石形成或促进CaOx溶解。我们还研究了该提取物在体内作为大鼠实验性诱导CaOx肾结石预防和治疗剂的效果。在体内实验结束时,对肾组织和尿液中的各种生化、分子和组织学参数进行了评估。
与对照处理相比(分别为55.10±4.98和54.57±5.84),用64mg/mL的RPA提取物处理后,体外观察到已形成晶体的显著溶解(8.99±1.43)和晶体形成的抑制(2.55±0.21)(p<0.05)。在预防方案中,与对照相比,RPA提取物显著降低了尿液和肾脏中的草酸盐水平,并增加了尿液中的钙和柠檬酸盐水平。此外,与对照相比,RPA预防方案显著降低了骨桥蛋白表达、肾脏结晶和病理变化。在治疗方案的大鼠中未观察到这些变化。
RPA是预防CaOx肾结石形成的有效药物。